Paul L Berns - Net Worth and Insider Trading
Paul L Berns Net Worth
The estimated net worth of Paul L Berns is at least $3 Million dollars as of 2024-04-28. Paul L Berns is the President and CEO of Anacor Pharmaceuticals Inc and owns about 230,311 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $2 Million. Paul L Berns is the Director of Jazz Pharmaceuticals PLC and owns about 8,290 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $907,423. Paul L Berns is also the Director of Cellectar Biosciences Inc and owns about 1,174 shares of Cellectar Biosciences Inc (CLRB) stock worth over $3,557. Details can be seen in Paul L Berns's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul L Berns has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).
Transaction Summary of Paul L Berns
Paul L Berns Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul L Berns owns 8 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) , Unity Biotechnology Inc (UBX) , and VYNE Therapeutics Inc (VYNE) among others .
Click here to see the complete history of Paul L Berns’s form 4 insider trades.
Insider Ownership Summary of Paul L Berns
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals PLC | 2021-08-05 | director |
| UBX | Unity Biotechnology Inc | 2020-06-18 | director |
| VYNE | VYNE Therapeutics Inc | 2019-06-25 | director |
| ANAC | Anacor Pharmaceuticals Inc | 2016-06-24 | director & President and CEO |
| XNPT | XenoPort Inc | 2016-05-17 | director |
| CLRB | Cellectar Biosciences Inc | 2016-04-20 | director |
| EQRX | EQRx Inc | 2021-12-17 | director |
| NMRA | Neumora Therapeutics Inc | 2023-09-14 | director |
Paul L Berns Latest Holdings Summary
Paul L Berns currently owns a total of 3 stocks. Among these stocks, Paul L Berns owns 230,311 shares of Anacor Pharmaceuticals Inc (ANAC) as of March 22, 2016, with a value of $2 Million and a weighting of 71.29%. Paul L Berns owns 8,290 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 5, 2021, with a value of $907,423 and a weighting of 28.6%. Paul L Berns also owns 1,174 shares of Cellectar Biosciences Inc (CLRB) as of April 20, 2016, with a value of $3,557 and a weighting of 0.11%.
Latest Holdings of Paul L Berns
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2016-03-22 | 230,311 | 9.82 | 2,261,654 |
| JAZZ | Jazz Pharmaceuticals PLC | 2021-08-05 | 8,290 | 109.46 | 907,423 |
| CLRB | Cellectar Biosciences Inc | 2016-04-20 | 1,174 | 3.03 | 3,557 |
Holding Weightings of Paul L Berns
Paul L Berns Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul L Berns has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 37,500 shares on March 22, 2016, which brought Paul L Berns around $2 Million.
According to the SEC Form 4 filings, Paul L Berns has made a total of 4 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,450 shares on August 5, 2021, which brought Paul L Berns around $223,300.
According to the SEC Form 4 filings, Paul L Berns has made a total of 0 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years. The most-recent trade in Cellectar Biosciences Inc is the acquisition of 1,174 shares on April 20, 2016, which cost Paul L Berns around $248,826.
Insider Trading History of Paul L Berns
- 1
Paul L Berns Trading Performance
GuruFocus tracks the stock performance after each of Paul L Berns's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul L Berns is 25.37%. GuruFocus also compares Paul L Berns's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul L Berns within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul L Berns's insider trading performs compared to the benchmark.
Performance of Paul L Berns
Average Return
2.93%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 68.29 | 25.37 | 1.95 | 2.93 | -27.08 | -51.56 |
| Relative Return to S&P 500(%) | 70.67 | 22.01 | 0.1 | -9.12 | -39.78 | -62.96 |
Paul L Berns Ownership Network
Ownership Network List of Paul L Berns
Ownership Network Relation of Paul L Berns
Paul L Berns Owned Company Details
What does Jazz Pharmaceuticals PLC do?
Who are the key executives at Jazz Pharmaceuticals PLC?
Paul L Berns is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include VP & Finance& PAO Patricia Carr , SVP & General Counsel Neena M Patil , and director & 10 percent owner Patrick G Enright .
Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary
Over the past 18 months, Paul L Berns made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 6,364 shares made by Patricia Carr , a net sale of 7,360 shares made by Neena M Patil , and a net sale of 7,000 shares made by Bruce C Cozadd .
In summary, during the past 3 months, insiders sold 3,704 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 12,000 shares, with a net purchase of 8,296 shares. During the past 18 months, 64,701 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 52,701 shares.
Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jazz Pharmaceuticals PLC Insider Transactions
Paul L Berns Mailing Address
Above is the net worth, insider trading, and ownership report for Paul L Berns. You might contact Paul L Berns via mailing address: 11080 Circlepoint Rd., Ste, 200, Westminster Co 80020.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
